In particular, our findings indicating that loss of Casp2 impacts neuronal differentiation, is likely a key contributor to delaying neuroblastoma onset and reduced adrenal tumor development in Th-MYCN/Casp2−/− mice. This evidence concerns the gene MYCN and adrenal gland neoplasm.